A monthly injection could enable severe asthma patients to stop taking daily steroid tablets without affecting their symptoms, a new trial has found. The drug, Tezepelumab (also known as Tezspir and ...
A monthly injection for managing severe asthma could help patients safely reduce or even discontinue daily steroid ...
Unlocking the Secrets of Severe Asthma: From Pathways to Precision is the launch of the brand new reelCE™ initiative, designed to educate U.S.-based pulmonologists, allergists, nurse practitioners, ...
Individuals with severe type 2 asthma and chronic rhinosinusitis with nasal polyps may benefit from the biologic treatment, dupilumab. A study on the efficacy of the biologic drug, dupilumab, found ...
A clinical trial to determine the best intravenous (IV) treatments for children with severe asthma will go ahead thanks to an almost $5 million ...
GSK plc GSK announced that the FDA has approved Exdensur (depemokimab-ulaa), an ultra-long-acting IL-5–targeting biologic, as an add-on maintenance treatment of severe asthma with an eosinophilic ...
India Education Diary on MSN
New clinical trial to compare the effectiveness of IV treatments for severe asthma in children
India, Jan. 24 -- A clinical trial to determine the best intravenous (IV) treatments for children with severe asthma will go ...
AstraZeneca ((AZN)) announced an update on their ongoing clinical study. Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to ...
Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window When I look ...
A landmark study has shown that severe asthma can be controlled using biologic therapies, without the addition of regular high-dose inhaled steroids which can have significant side effects. The ...
LONDON (Reuters) - AstraZeneca hopes to convince doctors its experimental injection for severe asthma has an edge over two approved rivals after clinical trials data on Monday showed it worked well ...
PARIS — Pregnancy is a period of asthma instability; it entails an increased risk for exacerbations. While therapeutic de-escalation, if not the outright cessation of maintenance treatment, is common, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results